Literature DB >> 21925959

Implementation of a community pharmacy-based falls prevention program.

Carri Casteel1, Susan J Blalock, Stefanie Ferreri, Mary T Roth, Karen B Demby.   

Abstract

BACKGROUND: Falls are the leading cause of fatal and nonfatal unintentional injury among older adults in the United States. Multifaceted falls prevention programs, which have been reported to reduce the risk for falls among older adults, usually include a medication review and modification component. Based on a literature search, no randomized trials that have examined the effectiveness of this component have been published.
OBJECTIVE: The aim of this article was to report on a retrospective process evaluation of data from a randomized, controlled trial conducted to examine the effectiveness of a medication review intervention, delivered through community pharmacies, on the rate of falls among community-dwelling older adults.
METHODS: Patients were recruited through 32 pharmacies in North Carolina. Participants were community-dwelling older adults at high risk for falls based on age (≥ 65 years), number of concurrent medications (≥ 4), and medication classes (emphasis on CNS-active agents). The process evaluation measured the recruitment of patients into the study, the process through which the intervention was delivered, the extent to which patients implemented the recommendations for intervention, and the acceptance of pharmacists' recommendations by prescribing physicians.
RESULTS: Of the 7793 patients contacted for study participation, 981 (12.6%) responded to the initial inquiry. A total of 801 (81.7%) participated in an eligibility interview, of whom 342 (42.7%) were eligible. Baseline data collection was completed in 186 of eligible patients (54.4%), who were randomly assigned to the intervention group (n = 93) or the control group (n = 93). Pharmacists delivered a medication review to 73 of the patients (78.5%) in the intervention group, with 41 recommendations for changes in medication, of which 10 (24.4%) were implemented. Of the 31 prescribing physicians contacted with pharmacists' recommendations, 14 (45.2%) responded, and 10 (32.3%) authorized the changes.
CONCLUSIONS: Based on the findings from the present study, coordination of care between community pharmacists and prescribers needs to be improved for the realization of potential beneficial effects of medication management on falls prevention.
Copyright © 2011 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925959     DOI: 10.1016/j.amjopharm.2011.08.002

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  5 in total

1.  Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice.

Authors:  Claire Browne; Claire Kingston; Claire Keane
Journal:  Int J Clin Pharm       Date:  2014-08-10

2.  Impact of a medication therapy management intervention targeting medications associated with falling: Results of a pilot study.

Authors:  David A Mott; Beth Martin; Robert Breslow; Barb Michaels; Jeff Kirchner; Jane Mahoney; Amanda Margolis
Journal:  J Am Pharm Assoc (2003)       Date:  2016-01

Review 3.  Interventions for preventing falls in older people living in the community.

Authors:  Lesley D Gillespie; M Clare Robertson; William J Gillespie; Catherine Sherrington; Simon Gates; Lindy M Clemson; Sarah E Lamb
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

4.  Training and Toolkit Resources to Support Implementation of a Community Pharmacy Fall Prevention Service.

Authors:  Jessica M Robinson; Chelsea P Renfro; Sarah J Shockley; Susan J Blalock; Alicia K Watkins; Stefanie P Ferreri
Journal:  Pharmacy (Basel)       Date:  2019-08-09

5.  A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.

Authors:  Joshua Niznik; Stefanie P Ferreri; Lori Armistead; Benjamin Urick; Mary-Haston Vest; Liang Zhao; Tamera Hughes; J Marvin McBride; Jan Busby-Whitehead
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.